Long-Term Outcomes of Congenital Adrenal Hyperplasia

Endocrinol Metab (Seoul). 2022 Aug;37(4):587-598. doi: 10.3803/EnM.2022.1528. Epub 2022 Jul 8.

Abstract

A plethora of negative long-term outcomes have been associated with congenital adrenal hyperplasia (CAH). The causes are multiple and involve supra-physiological gluco- and mineralocorticoid replacement, excess adrenal androgens both intrauterine and postnatal, elevated steroid precursor and adrenocorticotropic hormone levels, living with a congenital condition as well as the proximity of the cytochrome P450 family 21 subfamily A member 2 (CYP21A2) gene to other genes. This review aims to discuss the different long-term outcomes of CAH.

Keywords: Bone fracture; Cardiovascular diseases; Fertility; Mental disorders; Mortality; Neoplasms.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Hyperplasia, Congenital* / complications
  • Adrenal Hyperplasia, Congenital* / genetics
  • Humans
  • Steroid 21-Hydroxylase / genetics

Substances

  • CYP21A2 protein, human
  • Steroid 21-Hydroxylase